The Institute was set up as a legal entity in Spring 2018, later becoming a registered charity. The board for the Institute, also acting as its trustees, will be made up of members nominated by member organisations, plus representation from industry and affiliated organisations.
There are several layers of governance which control the finances and decision making at the Institute.
The Board of Directors – the board are the trustees for the charity, with legal responsibilities to ensure the safe and effective management of the Institute.
Member representatives – this group represent the interests of the member organisations, and their role is to ensure that the institute is delivering strong partnerships with its members.
The Value for Money Panel – this panel consider all major funding decisions, and assess their viability and value for money. Only proposals with the support of the Executive Team and relevant Theme Advisory Panels will be submitted to the Value for Money panel.
The Executive Team – the executive is made up of the senior leadership team for the Institute, plus the theme leaders. They consider developments across the themes and form part of the decision making in advancing proposals to the Value for Money Panel.
Strategic Advisory Board – has been established to advise the Franklin, via its Board on the development and implementation of the research and development strategy of the institute. Members are independent experts from academia and industry, both national and international. The SAB met for the first time in February 2020 and reviewed the current direction and future plans for each theme.
Theme Advisory Panels – each theme has a panel of international experts from across academia and industry who contribute to the development and review of the road-maps and technology proposals for each theme.
Board of Directors
Professor James Naismith
Professor Naismith grew up in Hamilton, in the west of Scotland attending local state schools. He graduated from Edinburgh in […]
Dr Vivienne Cox
Dr Vivienne Cox was appointed as Chair of the Rosalind Franklin Institute in 2018. A chemistry graduate with a passion for […]
Dr David Rees
Board Member, Astex Pharmaceuticals
David is Chief Scientific Officer at Astex Pharmaceuticals, Cambridge UK. He is associated with the discovery of three launched drugs, […]
Professor Mathias Gautel
Board Member, King’s College London
Mathias is the BHF Professor of Molecular Cardiology at King’s College London, whose research is focused the contractile structures of […]
Professor Helen Cooper
Board member, University of Birmingham
Helen is Professor of Mass Spectrometry and EPSRC Fellow in the School of Biosciences at the University of Birmingham. Her […]
Professor Nora de Leeuw
Board Member, University of Leeds
Nora is Professor of Computational Chemistry, whose research is focused on the atomic-level understanding of composite materials for biomedical applications […]
Dr Gillian Burgess
Board Member, Grünenthal
Gillian Burgess joined Grünenthal as Head of Research in April 2020. Prior to this she was the Vice President, Site Head […]
Professor Stephen Caddick
Board Member, Wellcome Trust
Stephen joined Wellcome as Director of Innovation in June 2015. Previously, he was Vice Provost (Enterprise & London) and Vernon Professor of […]
Board Member, Manchester University
Stephen is Director of Finance at The University of Manchester. He was previously Chief Finance Officer and Board member of […]
Dr Barbara Ghinelli
Board Member - UKRI-STFC
Barbara is Harwell Campus Business Development Director at UKRI-STFC, where she oversees the development and management of clusters on the […]
Professor Ewan McKendrick
Board Member, University of Oxford
Ewan is Professor of English Private Law and a Fellow of Lady Margaret Hall at the University of Oxford. He holds […]
Professor Nigel Titchener-Hooker
Board Member, UCL
Professor Nigel Titchener-Hooker, CENg, FIChemE, FREng is Dean of UCL Engineering and was for the past 7 years head of […]